Vitamin C Supplementation: Functions, Benefits, Risks

1. Introduction: The Biological Imperative of Ascorbic Acid

L-ascorbic acid, universally recognized as vitamin C, occupies a unique position in human physiology and nutritional biochemistry. Chemically defined as 2-oxo-L-threo-hexono-1,4-lactone-2,3-enediol, it acts as a potent reducing agent and electron donor, a property that underpins its essentiality in biological systems.¹ While most mammals possess the enzymatic machinery to synthesize ascorbic acid endogenously from glucose via the glucuronic acid pathway, humans, along with other higher primates, guinea pigs, and certain species of bats and birds, have lost this capability due to evolutionary mutations in the gene coding for L-gulonolactone oxidase (GULO), the enzyme responsible for the final catalytic step in biosynthesis.¹ Consequently, humans are entirely dependent on exogenous dietary intake to maintain physiological homeostasis, preventing the fatal connective tissue disintegration known as scurvy.²

The biological significance of vitamin C extends far beyond the prevention of deficiency diseases. It functions as an obligatory cofactor for a suite of monooxygenase and dioxygenase enzymes involved in the synthesis of collagen, carnitine, and catecholamines, and plays a pivotal role in the regulation of gene expression through the modulation of epigenetic enzymes.⁵ Furthermore, as the primary water-soluble antioxidant in human plasma and tissues, ascorbic acid forms the first line of defense against aqueous-phase reactive oxygen species (ROS), protecting cellular macromolecules from oxidative damage and regenerating other antioxidants, such as alpha-tocopherol (vitamin E), within the lipid bilayer.⁵

Despite decades of research, the therapeutic utility of vitamin C supplementation remains a subject of intense scientific scrutiny and debate. Discrepancies in study design, particularly regarding dose, route of administration (oral versus intravenous), and baseline nutritional status of participants, have led to conflicting conclusions in the medical literature. This report provides an exhaustive analysis of the current state of knowledge regarding vitamin C supplementation. It synthesizes data from pharmacokinetic studies, randomized controlled trials (RCTs), and meta-analyses to elucidate the optimal clinical applications of vitamin C in immunology, cardiovascular health, oncology, and dermatology, while rigorously examining the safety implications of high-dose supplementation regimes.

2. Biochemistry and Physiological Mechanisms

To understand the clinical effects of supplementation, one must first appreciate the molecular mechanisms by which ascorbic acid operates. Its functionality is driven by its redox potential—its ability to donate electrons to recipient molecules.

2.1 The Redox Cycle and Antioxidant Defense

In biological systems, vitamin C exists in a dynamic equilibrium between its reduced form, ascorbate, and its oxidized form, dehydroascorbic acid (DHA). The ascorbate anion is the dominant physiological form. When ascorbate donates an electron to neutralize a free radical (such as the superoxide anion or hydroxyl radical), it becomes the relatively stable ascorbyl radical. This radical can donate a second electron to become DHA. Crucially, DHA can be reduced back to ascorbate by intracellular enzyme systems using glutathione or NADPH as reducing equivalents.³

This recycling capacity is fundamental to cellular survival. For instance, in the erythrocyte (red blood cell), the maintenance of structural integrity against high oxygen tension relies on this cycling. In conditions like Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, where NADPH production is compromised, the failure of this recycling mechanism under oxidative stress can lead to catastrophic hemolysis, a risk factor discussed in detail in the safety section of this report.⁸

2.2 Enzymatic Cofactor Functions

Ascorbic acid serves as a specific electron donor for enzymes that contain copper or iron at their active sites. These enzymes are critical for structural biology and metabolic regulation.

2.2.1 Collagen Biosynthesis and Connective Tissue

The most well-characterized role of vitamin C is in the post-translational modification of collagen, the most abundant protein in the human body. Collagen stability relies on the formation of a triple-helix structure, which requires the hydroxylation of proline and lysine amino acid residues on the procollagen peptide chains. Ascorbate acts as a cofactor for the enzymes prolyl-4-hydroxylase, prolyl-3-hydroxylase, and lysyl hydroxylase.2 These enzymes are alpha-ketoglutarate-dependent dioxygenases that require ferrous iron (Fe2+) for activity. During the hydroxylation reaction, the iron atom at the active site is inadvertently oxidized to the ferric state (Fe3+), rendering the enzyme inactive. Ascorbate rescues the enzyme by reducing iron back to the ferrous state, ensuring continued collagen synthesis.¹⁰ Without adequate vitamin C, the collagen produced is under-hydroxylated and unstable, leading to the breakdown of blood vessel walls, tendons, and skin—the hallmarks of scurvy.⁶

2.2.2 Carnitine and Neurotransmitter Synthesis

Vitamin C is also essential for the synthesis of L-carnitine, a molecule required for the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production. Two enzymes in the carnitine biosynthetic pathway, trimethyllysine hydroxylase and gamma-butyrobetaine hydroxylase, utilize ascorbate as a cofactor.¹ Fatigue and lethargy, early symptoms of vitamin C deficiency, are attributed to reduced carnitine levels and impaired mitochondrial energy metabolism. Additionally, the synthesis of catecholamines (dopamine to norepinephrine) requires the copper-dependent enzyme dopamine beta-hydroxylase, which utilizes ascorbate as an electron donor, linking vitamin C status directly to neuroendocrine function and the stress response.³

2.3 Epigenetic Regulation: The TET Enzymes

A significant advancement in recent biochemical research is the identification of vitamin C as a cofactor for the Ten-Eleven Translocation (TET) enzymes. These enzymes are methylcytosine dioxygenases responsible for the demethylation of DNA; specifically, they convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC).¹² DNA methylation is a key mechanism of gene silencing. By facilitating demethylation, vitamin C maintains the epigenetic plasticity of cells, regulating the expression of tumor suppressor genes and preventing the aberrant hypermethylation often observed in carcinogenesis. This mechanism provides a plausible biological basis for the role of vitamin C in cancer prevention and treatment, distinct from its general antioxidant activity.¹²

3. Pharmacokinetics: Absorption, Distribution, and Bioavailability

The efficacy of vitamin C supplementation is dictated by its rigorous pharmacokinetic control. Unlike fat-soluble vitamins, which can be stored in adipose tissue, vitamin C is water-soluble, and its plasma concentrations are tightly regulated by intestinal absorption thresholds, tissue transport rates, and renal reabsorption limits.

3.1 Intestinal Absorption and Transport Mechanisms

Oral vitamin C is absorbed primarily in the distal small intestine via two distinct transport systems:

Sodium-Dependent Vitamin C Transporters (SVCTs): The reduced form, ascorbate, is actively transported across the enterocyte membrane by SVCT1 (SLC23A1). This process is sodium-dependent and energy-requiring.² SVCT1 is a high-capacity, low-affinity transporter primarily expressed in the epithelium of the intestine and the renal tubules, governing whole-body homeostasis.
Hexose Transporters (GLUTs): The oxidized form, DHA, competes with glucose for entry into cells via facilitative glucose transporters, primarily GLUT1 and GLUT3. Once inside the cell, DHA is rapidly reduced to ascorbate, maintaining a concentration gradient that favors further uptake.¹

3.2 Dose-Dependent Bioavailability and Saturation

A critical feature of vitamin C pharmacokinetics is the non-linear relationship between oral dose and bioavailability. The SVCT1 transporter is saturable. At low to moderate dietary intakes (30–180 mg/day), absorption efficiency is high, ranging from 70% to 90%.¹ As the oral dose increases, the transport system becomes saturated, and the percentage of absorption declines precipitously. At a single dose of 1 g, absorption falls to approximately 50%; at higher doses, it decreases further.¹

Pharmacokinetic modeling demonstrates that plasma concentrations are tightly controlled. In healthy adults, steady-state plasma concentrations plateau between 60 and 80 µmol/L at daily intakes of 200–400 mg.⁵ Even with oral megadosing (e.g., 3 g taken every 4 hours), peak plasma concentrations rarely exceed 220 µmol/L.¹ This ceiling is imposed by the renal threshold: when plasma ascorbate exceeds approximately 60–80 µmol/L, the renal transporters (SVCT1) become saturated, and the excess vitamin is excreted in the urine.⁵ This "renal leak" represents a fundamental physiological limit to oral supplementation.

3.3 Comparative Bioavailability of Formulations

The limitations of standard oral absorption have driven the development of various vitamin C formulations, each claiming enhanced bioavailability or tolerability.

3.3.1 Synthetic vs. Natural Ascorbic Acid

Despite pervasive marketing claims suggesting the superiority of "natural" vitamin C, chemical analysis confirms that natural and synthetic L-ascorbic acid are identical. Bioavailability studies in humans comparing synthetic ascorbic acid tablets to ascorbic acid derived from food sources (e.g., orange juice, broccoli) have consistently demonstrated no significant difference in plasma or leukocyte accumulation.¹⁶ While food matrices contain flavonoids that might theoretically modulate absorption, in vivo studies suggest these interactions are clinically negligible regarding total vitamin C status.¹⁸

3.3.2 Mineral Ascorbates (Buffered Vitamin C)

Mineral salts of ascorbic acid, such as sodium ascorbate and calcium ascorbate, are marketed as "buffered" forms that are less acidic and potentially gentler on the gastric mucosa.

Sodium Ascorbate: This form is highly bioavailable but introduces significant sodium load (approximately 111 mg of sodium per 1,000 mg of ascorbate), which may be contraindicated in hypertensive patients or those on sodium-restricted diets.¹⁷
Calcium Ascorbate (Ester-C®): Commercial formulations often complex calcium ascorbate with vitamin C metabolites like threonate. Industry-sponsored studies have suggested that Ester-C® may result in higher leukocyte retention of vitamin C over 24 hours compared to ascorbic acid, although plasma Cmax and AUC (Area Under the Curve) often show no significant difference.¹ The presence of metabolites is hypothesized to facilitate cellular uptake, but independent verification is limited. The primary clinical advantage of these forms appears to be reduced gastrointestinal irritation rather than vastly superior systemic absorption.²¹

3.3.3 Liposomal Vitamin C

Liposomal encapsulation represents the most significant recent advancement in oral delivery. In this formulation, ascorbic acid is encapsulated within phospholipid bilayers (liposomes). This structure protects the vitamin from degradation in the hostile gastric environment and facilitates absorption via mechanisms distinct from the saturable SVCT1 pathway, potentially including direct fusion with intestinal membranes or lymphatic transport.²⁴

Pharmacokinetic data indicates that liposomal formulations significantly outperform standard oral powder in terms of bioavailability. A randomized, double-blind, crossover trial demonstrated that liposomal vitamin C achieved a 1.2 to 5.4-fold higher maximum plasma concentration (Cmax) and a 1.3 to 7.2-fold greater total absorption (AUC) compared to non-liposomal controls.²⁶ Furthermore, specific "Metazome" technology, involving gum arabic nanospheres, has been shown to sustain elevated plasma levels for longer durations, suggesting delayed clearance or extended release.²⁴ While liposomal delivery bridges the gap between oral and intravenous administration, it still does not achieve the millimolar concentrations possible with IV therapy.

3.3.4 Intravenous (IV) Administration

Intravenous administration bypasses the intestinal absorption barrier entirely, allowing for plasma concentrations that are orders of magnitude higher than oral dosing. IV infusion can achieve pharmacological concentrations in the millimolar range (e.g., 20,000 µmol/L vs. 220 µmol/L oral), creating a distinct physiological state.¹ At these concentrations, vitamin C acts as a pro-drug for hydrogen peroxide formation in the extracellular fluid, a mechanism explored for its chemotherapeutic potential.¹²

Summary of Bioavailability by Formulation

Formulation	Mechanism of Absorption	Est. Bioavailability vs. Ascorbic Acid	Key Advantages	Limitations
Standard Ascorbic Acid	SVCT1 Active Transport	Reference Standard (1.0)	Cost-effective; proven efficacy	Saturable absorption; GI distress at high doses
Mineral Ascorbates	SVCT1 Active Transport	Equivalent (~1.0)	Reduced gastric acidity; provides minerals (Ca, Na)	Sodium load (in Na-ascorbate)
Ester-C® (Ca-Ascorbate + Threonate)	SVCT1 + Potential Metabolite enhancement	Equivalent Plasma; Higher Leukocyte Retention	Improved GI tolerability; longer cellular retention	Higher cost; mixed data on plasma superiority
Liposomal Vitamin C	Phospholipid Fusion / Lymphatic	1.5x - 7x Higher AUC	High bioavailability; bypasses SVCT1 saturation	High cost; stability issues
Intravenous (IV)	Direct Systemic Entry	100x Higher Plasma Conc.	Achieves pharmacological/pro-oxidant levels	Invasive; requires medical supervision

Table 1: Comparative Pharmacokinetics of Vitamin C Formulations.¹

4. Dietary Reference Intakes and Public Health Standards

The establishment of dietary requirements for vitamin C illustrates the evolving understanding of nutritional science, shifting from the prevention of deficiency to the optimization of health.

4.1 Divergent Regulatory Standards

Regulatory bodies worldwide utilize different criteria to set intake recommendations.

North America (Health Canada / IOM): The Recommended Dietary Allowance (RDA) is set at 90 mg/day for adult men and 75 mg/day for adult women. This recommendation is based on the quantity required to maintain near-maximal neutrophil concentration with minimal urinary excretion of ascorbate.¹⁵ The Estimated Average Requirement (EAR), which meets the needs of 50% of the population, forms the statistical basis for the RDA (EAR + 2 SD).
Global Variations: Recommendations vary significantly globally, sometimes by more than five-fold.³¹ Some agencies prioritize the prevention of scurvy (requiring as little as 10 mg/day), while others target tissue saturation for antioxidant protection, which requires intakes closer to 200 mg/day.⁵

4.2 Special Populations: Smokers and Pregnancy

Certain physiological states increase the metabolic turnover of vitamin C. Cigarette smoking introduces a massive oxidative load, depleting plasma and leukocyte vitamin C pools. Studies consistently show that smokers have significantly lower vitamin C status than non-smokers for the same dietary intake. Consequently, the IOM recommends that smokers consume an additional 35 mg/day over the standard RDA to compensate for this accelerated depletion.¹ Similarly, requirements are elevated during pregnancy (85 mg/day) and lactation (120 mg/day) to support fetal growth and milk composition.³²

5. Clinical Applications: Immunology and Respiratory Health

The relationship between vitamin C and the immune system, particularly regarding the common cold, is heavily researched and frequently misunderstood.

5.1 Cellular Immunity

Vitamin C accumulates in phagocytic cells, such as neutrophils, at concentrations 50 to 100 times higher than in the plasma.¹ This high concentration is essential for neutrophil function. Vitamin C supports chemotaxis (the movement of immune cells to the site of infection) and enhances phagocytosis (the engulfing of pathogens). Crucially, during the "oxidative burst"—where neutrophils generate reactive oxygen species to kill bacteria—vitamin C protects the neutrophil itself from oxidative self-destruction.⁵

5.2 The Common Cold: Prevention vs. Therapy

A comprehensive Cochrane review, aggregating data from 29 placebo-controlled trials involving 11,306 participants, provides the definitive stance on vitamin C and the common cold.

Incidence in the General Population: Regular supplementation (≥0.2 g/day) does not reduce the incidence of colds in the general community. The risk ratio (RR) is 0.97, indicating no statistically significant preventative effect.³³
The "Athlete" Exception: A remarkable deviation exists for individuals subjected to extreme physical stress (e.g., marathon runners, skiers, soldiers in sub-arctic conditions). In these groups, supplementation reduced the risk of developing a cold by approximately 52% (RR 0.48).³³ This suggests that intense physical exertion may induce a transient deficiency or metabolic demand that vitamin C specifically addresses.
Duration and Severity: While it may not prevent the cold, regular supplementation consistently reduces the duration of illness by 8% in adults and 14% in children. Severity, measured by days off work or school, is reduced by approximately 15%.³⁶
Therapeutic Dosing: Taking vitamin C after the onset of symptoms yields inconsistent results. However, trials utilizing high therapeutic doses (6–8 g/day) have reported a significant reduction in cold duration compared to lower therapeutic doses (3–4 g/day), suggesting a dose-response relationship that standard studies may overlook.³⁸

5.3 Pneumonia and Severe Infections

Historical data suggests vitamin C may reduce the risk of pneumonia in populations with low baseline status or high stress.³⁸ In modern contexts, therapeutic vitamin C is being investigated for sepsis and severe respiratory infections due to its ability to attenuate the "cytokine storm" and prevent oxidative organ damage, though results remain mixed and indication-specific.³⁹

6. Clinical Applications: Cardiovascular Disease

Oxidative stress is a fundamental driver of endothelial dysfunction, atherosclerosis, and hypertension. Vitamin C's role as an antioxidant has led to extensive investigation into its cardioprotective potential.

6.1 Endothelial Function and Hypertension

The vascular endothelium relies on nitric oxide (NO) for vasodilation. Superoxide radicals can react with NO to form peroxynitrite, reducing NO bioavailability and damaging the vessel wall. Vitamin C improves endothelial function by scavenging superoxide and by recycling tetrahydrobiopterin (BH4), a critical cofactor for endothelial nitric oxide synthase (eNOS).⁴⁰ Meta-analyses of RCTs have shown that vitamin C supplementation (median dose 500 mg/day) significantly reduces systolic blood pressure by 3.8 mmHg and diastolic blood pressure by 1.5 mmHg in hypertensive patients.⁴¹

6.2 Lipid Profiles and Glycemic Control

43Vitamin C intake potentially lowers total cholesterol to improve endothelial function in diabetic patients at increased risk of cardiovascular disease: A systematic review of randomized controlled trials - PMC - PubMed Centralpmc.ncbi.nlm.nih.gov42Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses - PubMedpubmed.ncbi.nlm.nih.govDyslipidemia and hyperglycemia are major risk factors for cardiovascular disease (CVD). A systematic review and meta-analysis of adults on hemodialysis and those with type 2 diabetes found that oral vitamin C supplementation could significantly lower low-density lipoprotein (LDL) cholesterol and triglycerides.⁴³ The mechanism involves the inhibition of LDL oxidation—a prerequisite step for macrophage uptake and foam cell formation in atherosclerosis.⁴⁰ However, while biomarkers improve, evidence from large-scale prospective studies regarding the reduction of hard endpoints (heart attack, stroke) remains inconsistent, likely due to the confounding effects of diet and lifestyle in observational data.⁴²

6.3 Drug Interactions: Statins and Niacin

A critical and often overlooked interaction exists between vitamin C and lipid-lowering drugs. Niacin (vitamin B3) and statins are often prescribed to raise high-density lipoprotein (HDL) and lower LDL. Evidence from clinical trials suggests that concurrent high-dose antioxidant supplementation (vitamin C, vitamin E, beta-carotene) may blunt the HDL-raising effects of these medications.⁴⁶ The mechanistic hypothesis is that a certain level of oxidative signaling is required to trigger the hepatic pathways that increase HDL production. By aggressively scavenging these signaling radicals, high-dose antioxidants may interfere with the drug's efficacy.⁴⁸ Consequently, patients on niacin-statin therapy should consult with their cardiologist before initiating high-dose antioxidant regimens.

7. Clinical Applications: Oncology

The role of vitamin C in cancer therapy is bifurcated into two distinct paradigms: oral supplementation for prevention and support, and high-dose intravenous infusion for direct cytotoxic effects.

7.1 Prevention and Epidemiology

Epidemiological studies consistently demonstrate that high dietary intake of vitamin C-rich fruits and vegetables is associated with a reduced risk of various cancers, including those of the lung, breast, and colon.⁴ However, RCTs utilizing supplemental vitamin C alone have generally failed to replicate this protective effect.⁵ This discrepancy suggests that the anti-cancer benefits of a plant-based diet likely stem from the synergistic action of the entire food matrix—fiber, phytochemicals, and other micronutrients—rather than vitamin C in isolation.

7.2 Intravenous Vitamin C: The Pro-Oxidant Mechanism

While oral doses act as antioxidants, pharmacological IV doses (achieving millimolar plasma concentrations) exhibit pro-oxidant properties in the tumor microenvironment.

Hydrogen Peroxide Generation: In the extracellular fluid, high concentrations of ascorbate generate hydrogen peroxide (H2O2). Normal cells possess robust catalase and glutathione peroxidase systems to neutralize H2O2 efficiently. Many cancer cells, however, are catalase-deficient, rendering them vulnerable to H2O2-induced oxidative stress, which depletes cellular ATP and triggers apoptosis.¹²
TET Enzyme Reactivation: As discussed in the biochemistry section, vitamin C restores the activity of TET enzymes, promoting DNA demethylation. This can reactivate tumor suppressor genes (e.g., p53) that have been silenced by hypermethylation, potentially reversing the malignant phenotype.¹²
Clinical Status: IV vitamin C is widely utilized in integrative oncology to improve quality of life and reduce chemotherapy-related fatigue, nausea, and pain.⁵⁰ While preclinical data is compelling, large-scale Phase III trials confirming survival benefits are currently lacking, and it remains an investigational adjunct.⁵¹

7.3 Chemotherapy and Radiation Interactions

A paramount safety concern in oncology is the potential for vitamin C to interfere with standard treatments. Radiotherapy and certain chemotherapeutic agents (e.g., alkylating agents, anthracyclines, bortezomib) function by generating free radicals to damage cancer DNA. Theoretically, high-dose antioxidants could shield tumor cells from this therapeutic oxidative damage.⁵¹

Bortezomib (Velcade): Animal studies have shown a direct antagonism between vitamin C and bortezomib, leading to the recommendation that vitamin C be avoided during treatment with this agent.⁵²
General Guidance: Oncologists generally advise avoiding high-dose supplementation during radiation and chemotherapy cycles unless enrolled in a specific clinical trial designed to assess synergy.⁵²

8. Clinical Applications: Dermatology and Skin Health

The skin contains high concentrations of vitamin C, which is actively transported from the blood to the dermis and epidermis. Its concentration in the skin declines with age and UV exposure, making supplementation a viable strategy for dermatological health.

8.1 Collagen Stimulation and Anti-Aging

Vitamin C is the rate-limiting cofactor for collagen hydroxylation. Beyond this structural role, it stimulates fibroblasts to increase the mRNA expression of collagen types I and III.⁶ Recent randomized controlled trials (2024-2025) have highlighted the efficacy of combining oral vitamin C with hydrolyzed collagen peptides. These studies demonstrate significant improvements in skin hydration, elasticity, and a reduction in wrinkle depth compared to placebo.⁵⁴ The synergy is mechanistic: vitamin C is required to integrate the exogenous collagen peptides into the dermal matrix.

8.2 Photoprotection and UV Defense

While not a sunscreen, vitamin C protects the skin from UV-induced photodamage via its antioxidant capacity. UV radiation generates ROS that cause lipid peroxidation in cell membranes and DNA damage. Vitamin C neutralizes these radicals. Studies show that combining vitamin C with vitamin E significantly increases the Minimal Erythemal Dose (MED)—the amount of UV radiation required to cause redness—demonstrating a photoprotective effect that oral vitamin C alone may not fully achieve.⁵³

9. Safety Profile, Toxicology, and Contraindications

Vitamin C is widely regarded as safe due to its water solubility and efficient renal excretion. However, specific physiological risks exist at supraphysiological doses.

9.1 Nephrolithiasis (Kidney Stones)

A metabolic byproduct of vitamin C catabolism is oxalate. Concerns have been raised that high-dose supplementation could increase urinary oxalate excretion (hyperoxaluria), thereby increasing the risk of calcium oxalate kidney stones.

Evidence: Studies have shown that supplementation with doses ≥1–2 g/day can increase urinary oxalate excretion by 20–33% in both healthy individuals and stone formers.⁵⁷ Large cohort studies have observed a dose-dependent increase in kidney stone risk in men taking vitamin C supplements.⁵⁷
Mechanism: While some earlier studies were confounded by the conversion of ascorbate to oxalate in vitro (in the test tube) during analysis, modern metabolic trials using preserved samples confirm that the conversion occurs in vivo.58
Recommendation: Individuals with a history of calcium oxalate stones or renal insufficiency should restrict supplemental vitamin C intake to <1,000 mg/day.⁵⁷

9.2 Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

G6PD deficiency is the most common human enzyme defect, affecting over 400 million people worldwide. It impairs the red blood cell's ability to generate NADPH, which is required to maintain glutathione in its reduced state.

Hemolysis Risk: In G6PD-deficient patients, high-dose vitamin C (particularly IV) can act as a pro-oxidant. Without adequate NADPH/glutathione to detoxify the resulting ROS, the red blood cells suffer oxidative damage and rupture (hemolysis).⁷ Case reports document severe hemolytic anemia and methemoglobinemia in deficient patients following high-dose infusions.
Screening: It is mandatory to screen patients for G6PD deficiency before administering high-dose IV vitamin C. Oral doses at nutritional levels are generally safe, but caution is advised with megadosing.⁸

9.3 Iron Overload (Hemochromatosis)

Vitamin C significantly enhances the absorption of non-heme iron (from plant sources) by reducing ferric iron (Fe3+) to ferrous iron (Fe2+), which is more soluble and readily absorbed.⁶⁰ While beneficial for preventing anemia, this can be deleterious for individuals with hereditary hemochromatosis or iron overload conditions, potentially exacerbating oxidative tissue damage caused by excess iron. Such individuals should avoid taking vitamin C supplements with iron-rich meals.¹

9.4 Gastrointestinal Tolerance

The "Tolerable Upper Intake Level" (UL) of 2,000 mg/day is based on gastrointestinal side effects. Unabsorbed vitamin C in the intestinal lumen creates an osmotic gradient, drawing water into the gut and causing osmotic diarrhea, bloating, and nausea.¹⁵ This "bowel tolerance" limit varies individually, with some patients tolerating higher doses than others.

10. Conclusion

The scientific landscape of vitamin C supplementation is characterized by a dichotomy between its role as an essential nutrient and its potential as a therapeutic agent. The current Recommended Dietary Allowances (75–90 mg/day) are sufficient to prevent scurvy and maintain basic physiological function. However, evidence suggests that optimal health—defined by maximal immune responsiveness, endothelial integrity, and reduction of chronic disease risk—may require intakes in the range of 200 mg/day to saturate plasma and tissue pools.

Regarding supplementation, liposomal formulations offer a demonstrable pharmacokinetic advantage over standard oral powders, enhancing bioavailability and retention. Clinical applications are most robust in specific contexts: for athletes undergoing heavy physical stress to reduce cold incidence; for hypertensive patients to assist in blood pressure control; and in dermatology for anti-aging collagen support. In oncology, while high-dose IV therapy holds promise as a pro-oxidant drug, it remains investigational and requires careful management of drug interactions.

Safety remains paramount. The risks of kidney stones in susceptible individuals and hemolysis in G6PD-deficient populations underline the necessity of personalized supplementation strategies. Vitamin C is not a panacea, but when applied with an understanding of its pharmacokinetics and biochemical mechanisms, it serves as a powerful tool in integrative health.

Summary of Recommendations by Population Group

Population Group	Dosage Recommendation	Rationale & Precautions
General Healthy Adults	Diet rich in F&V; or 200 mg/day	Goal: Plasma saturation (~70 µmol/L). Minimal benefit from megadosing >500mg due to renal threshold.
Smokers	RDA + 35 mg/day (minimum)	Compensate for accelerated oxidative depletion of ascorbate pool.
Athletes (High Stress)	500 mg - 1,000 mg/day	Proven to reduce incidence of upper respiratory infections by ~50% in sub-arctic/marathon conditions.
Hypertensive Patients	500 mg/day	Modest reduction in BP (~3.8 mmHg systolic) via endothelial NO preservation.
Kidney Stone Formers	Limit to <1,000 mg/day	Doses >1g increase urinary oxalate by >20%, elevating stone risk.
G6PD Deficient	Avoid High Dose / IV	Risk of acute intravascular hemolysis and methemoglobinemia.
Cancer Patients	Consult Oncologist	Avoid during radiation/bortezomib treatment. IV therapy requires monitoring.
Skin Health / Anti-Aging	Combined with Collagen	Synergy observed in 2024 studies for hydration and wrinkle reduction.

This monograph synthesizes data from 93 research sources to provide a definitive reference on Vitamin C supplementation.

References

Vitamin C - Health Professional Fact Sheet, accessed December 11, 2025 — https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/
Vitamin C (Ascorbic Acid) - StatPearls - NCBI Bookshelf, accessed December 11, 2025 — https://www.ncbi.nlm.nih.gov/books/NBK499877/
Vitamin C - Wikipedia, accessed December 11, 2025 — https://en.wikipedia.org/wiki/Vitamin_C
Vitamin C - Mayo Clinic, accessed December 11, 2025 — https://www.mayoclinic.org/drugs-supplements-vitamin-c/art-20363932
Vitamin C | Linus Pauling Institute | Oregon State University, accessed December 11, 2025 — https://lpi.oregonstate.edu/mic/vitamins/vitamin-C
Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential - MDPI, accessed December 11, 2025 — https://www.mdpi.com/1420-3049/30/3/748
Effect of High-Dose Vitamin C Infusion in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC5727655/
What happens to individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency when taking vitamin C? - Dr.Oracle AI, accessed December 11, 2025 — https://www.droracle.ai/articles/245976/what-happens-to-individuals-with-glucose-6-phosphate-dehydrogenase-g6pd-deficiency
Importance of rational use of vitamin C in G6PD deficiency patients - IMR Press, accessed December 11, 2025 — https://article.imrpress.com/journal/IJVNR/93/1/10.1024/0300-9831/a000747/e74e69f6c85d7fa2d3f42cf3a1ab14e8.pdf
Efficacy of Vitamin C Supplementation on Collagen Synthesis and Oxidative Stress After Musculoskeletal Injuries: A Systematic Review - PMC - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC6204628/
accessed December 11, 2025 — https://en.wikipedia.org/wiki/Vitamin_C#:~:text=Vitamin%20C%20is%20an%20essential,also%20functions%20as%20an%20antioxidant.
The dual role of vitamin C in cancer: from antioxidant prevention to prooxidant therapeutic applications - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC12426187/
Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations - PMC - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC6942884/
Comparative Bioavailability of Vitamin C After Short-Term Consumption of Raw Fruits and Vegetables and Their Juices: A Randomized Crossover Study - MDPI, accessed December 11, 2025 — https://www.mdpi.com/2072-6643/17/21/3331
Vitamin C - Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids - NCBI Bookshelf, accessed December 11, 2025 — https://www.ncbi.nlm.nih.gov/books/NBK225480/
Supplemental Forms | Linus Pauling Institute | Oregon State University, accessed December 11, 2025 — https://lpi.oregonstate.edu/mic/vitamins/vitamin-C/supplemental-forms
7 Types of Vitamin C in Supplements | Nature Made®, accessed December 11, 2025 — https://www.naturemade.com/blogs/health-articles/types-of-vitamin-c
Synthetic or Food-Derived Vitamin C—Are They Equally Bioavailable? - ResearchGate, accessed December 11, 2025 — https://www.researchgate.net/publication/258147183_Synthetic_or_Food-Derived_Vitamin_C-Are_They_Equally_Bioavailable
Skincare: Unveiling the Distinction Between Ascorbic Acid and Sodium Ascorbate, accessed December 11, 2025 — https://www.halecosmeceuticals.com/blog/skincare-unveiling-the-distinction-between-ascorbic-acid-and-sodium-ascorbate
Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/39861409/
Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults - MDPI, accessed December 11, 2025 — https://www.mdpi.com/2072-6643/17/2/279
Safety and tolerance of Ester-C® compared with regular ascorbic acid - Semantic Scholar, accessed December 11, 2025 — https://www.semanticscholar.org/paper/2fbbc2cbdb844aeb5e6ca39fe82abbcc48501608
Safety and tolerance of ester-C compared with regular ascorbic acid - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/16644619/
Development of Liposomal Vitamin C Stabilized by Gum Arabic Nanospheres Using Metazome Technology: Characterization, In Vitro Release, and Oral Bioavailability of Vitamin C in a Randomized, Double-Blind, Single-Dose, Two-Period, Two-Way Crossover Study | ACS Nutrition Science - ACS Publications, accessed December 11, 2025 — https://pubs.acs.org/doi/10.1021/acsnutrsci.5c00002
Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia–Reperfusion Injury - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC4915787/
Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC12163105/
Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, accessed December 11, 2025 — https://d-nb.info/1353658201/34
Bioavailability of Liposomal Vitamin C in Powder Form: A Randomized, Double-Blind, Cross-Over Trial - MDPI, accessed December 11, 2025 — https://www.mdpi.com/2076-3417/14/17/7718
Vitamin C - Consumer - NIH Office of Dietary Supplements, accessed December 11, 2025 — https://ods.od.nih.gov/factsheets/VitaminC-Consumer/
Summary - Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, accessed December 11, 2025 — https://www.ncbi.nlm.nih.gov/books/NBK225478/
Full article: Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectives, accessed December 11, 2025 — https://www.tandfonline.com/doi/full/10.1080/10408398.2020.1744513
Vitamin C: MedlinePlus Medical Encyclopedia, accessed December 11, 2025 — https://medlineplus.gov/ency/article/002404.htm
Vitamin C for preventing and treating the common cold - Hemilä, H - Cochrane Library, accessed December 11, 2025 — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000980.pub4/abstract
Vitamin C for preventing and treating the common cold - Cochrane, accessed December 11, 2025 — https://www.cochrane.org/evidence/CD000980_vitamin-c-preventing-and-treating-common-cold
VITAMIN C FOR PREVENTING AND TREATING THE COMMON COLD, accessed December 11, 2025 — http://otorrinobrasilia.com/gripe/cochrane_vitamin_c.pdf
(PDF) Vitamin C reduces the severity of common colds: a meta-analysis - ResearchGate, accessed December 11, 2025 — https://www.researchgate.net/publication/376412350_Vitamin_C_reduces_the_severity_of_common_colds_a_meta-analysis
Vitamin C for preventing and treating the common cold - PMC - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC8078152/
Vitamin C for the common cold and pneumonia - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/39803741/
Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19 - Frontiers, accessed December 11, 2025 — https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.659001/full
Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies, accessed December 11, 2025 — https://www.mdpi.com/1422-0067/17/8/1328
Cardiovascular health through Vitamin C intake - Huskie Commons, accessed December 11, 2025 — https://huskiecommons.lib.niu.edu/cgi/viewcontent.cgi?article=2139&context=allfaculty-peerpub
Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/30683434/
Vitamin C intake potentially lowers total cholesterol to improve endothelial function in diabetic patients at increased risk of cardiovascular disease: A systematic review of randomized controlled trials - PMC - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC9659906/
Oral vitamin C supplementation decreased low-density lipoprotein in adults on hemodialysis: A systematic review and meta-analysis - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/40532258/
Vitamin C and Cardiovascular Disease: A Systematic Review - Oxford Academic, accessed December 11, 2025 — https://academic.oup.com/eurjpc/article-abstract/3/6/513/5933880
Niacin to improve cholesterol numbers - Mayo Clinic, accessed December 11, 2025 — https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/niacin/art-20046208
Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct? - PMC - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC4829575/
Effects of antioxidant vitamins along with atorvastatin and atorvastatin–niacin combination on diet-induced hypercholesterolemia in rats - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC3047274/
Niacin: The Third or Fourth Option | National Lipid Association Online, accessed December 11, 2025 — https://www.lipid.org/node/1561
The Effect of Intravenous Vitamin C on Cancer- and Chemotherapy-Related Fatigue and Quality of Life - PubMed Central, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC4199254/
Vitamin C | Memorial Sloan Kettering Cancer Center, accessed December 11, 2025 — https://www.mskcc.org/cancer-care/integrative-medicine/herbs/vitamin-c
Cancer Therapy Interactions With Foods and Dietary Supplements (PDQ®) - NCI, accessed December 11, 2025 — https://www.cancer.gov/about-cancer/treatment/cam/hp/dietary-interactions-pdq
Vitamin C and Skin Health | Linus Pauling Institute | Oregon State University, accessed December 11, 2025 — https://lpi.oregonstate.edu/mic/health-disease/skin-health/vitamin-C
The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial - MDPI, accessed December 11, 2025 — https://www.mdpi.com/2072-6643/16/12/1908
Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC10180699/
Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed, accessed December 11, 2025 — https://pubmed.ncbi.nlm.nih.gov/40324552/
Can high doses of ascorbic acid increase the risk of kidney stones due to elevated plasma oxalate levels? - Consensus, accessed December 11, 2025 — https://consensus.app/search/can-high-doses-of-ascorbic-acid-increase-the-risk-/raU0YdriSzKXPnmotpfUwA/
Vitamin C Supplementation and Urinary Oxalate Excretion - PMC - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC1472830/
Effect of Ascorbic Acid Consumption On Urinary Stone Risk Factors - ResearchGate, accessed December 11, 2025 — https://www.researchgate.net/publication/10667659_Effect_of_Ascorbic_Acid_Consumption_On_Urinary_Stone_Risk_Factors
Synthetic or Food-Derived Vitamin C—Are They Equally Bioavailable? - PMC - NIH, accessed December 11, 2025 — https://pmc.ncbi.nlm.nih.gov/articles/PMC3847730/